位置:首页 > 蛋白库 > ACKA_METTE
ACKA_METTE
ID   ACKA_METTE              Reviewed;         408 AA.
AC   P38502;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1994, sequence version 1.
DT   03-AUG-2022, entry version 118.
DE   RecName: Full=Acetate kinase {ECO:0000255|HAMAP-Rule:MF_00020};
DE            EC=2.7.2.1 {ECO:0000255|HAMAP-Rule:MF_00020};
DE   AltName: Full=Acetokinase {ECO:0000255|HAMAP-Rule:MF_00020};
GN   Name=ackA {ECO:0000255|HAMAP-Rule:MF_00020}; Synonyms=ack;
OS   Methanosarcina thermophila.
OC   Archaea; Euryarchaeota; Stenosarchaea group; Methanomicrobia;
OC   Methanosarcinales; Methanosarcinaceae; Methanosarcina.
OX   NCBI_TaxID=2210;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], CATALYTIC ACTIVITY, ACTIVITY REGULATION,
RP   AND BIOPHYSICOCHEMICAL PROPERTIES.
RC   STRAIN=ATCC 43570 / DSM 1825 / OCM 12 / TM-1;
RX   PubMed=8226623; DOI=10.1128/jb.175.21.6822-6829.1993;
RA   Latimer M.T., Ferry J.G.;
RT   "Cloning, sequence analysis, and hyperexpression of the genes encoding
RT   phosphotransacetylase and acetate kinase from Methanosarcina thermophila.";
RL   J. Bacteriol. 175:6822-6829(1993).
RN   [2]
RP   PROTEIN SEQUENCE OF 1-17, CATALYTIC ACTIVITY, SUBUNIT, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=2844814; DOI=10.1016/s0021-9258(19)37608-2;
RA   Aceti D.J., Ferry J.G.;
RT   "Purification and characterization of acetate kinase from acetate-grown
RT   Methanosarcina thermophila. Evidence for regulation of synthesis.";
RL   J. Biol. Chem. 263:15444-15448(1988).
RN   [3]
RP   CATALYTIC ACTIVITY, SUBUNIT, COFACTOR, AND MUTAGENESIS OF ASN-7; SER-10;
RP   SER-12; LYS-14; ASP-148; ASN-211 AND GLU-384.
RX   PubMed=11562377; DOI=10.1074/jbc.m108355200;
RA   Miles R.D., Iyer P.P., Ferry J.G.;
RT   "Site-directed mutational analysis of active site residues in the acetate
RT   kinase from Methanosarcina thermophila.";
RL   J. Biol. Chem. 276:45059-45064(2001).
RN   [4]
RP   CATALYTIC ACTIVITY, FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   MUTAGENESIS OF VAL-93; LEU-122; PHE-179 AND PRO-232.
RX   PubMed=15774882; DOI=10.1128/jb.187.7.2386-2394.2005;
RA   Ingram-Smith C., Gorrell A., Lawrence S.H., Iyer P., Smith K., Ferry J.G.;
RT   "Characterization of the acetate binding pocket in the Methanosarcina
RT   thermophila acetate kinase.";
RL   J. Bacteriol. 187:2386-2394(2005).
RN   [5]
RP   CATALYTIC ACTIVITY, SUBUNIT, BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS
RP   OF ARG-91 AND ARG-241.
RX   PubMed=17999468; DOI=10.1021/bi701292a;
RA   Gorrell A., Ferry J.G.;
RT   "Investigation of the Methanosarcina thermophila acetate kinase mechanism
RT   by fluorescence quenching.";
RL   Biochemistry 46:14170-14176(2007).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) IN COMPLEX WITH THE ATP ANALOG ADP,
RP   ACTIVE SITE, AND SUBUNIT.
RX   PubMed=11133963; DOI=10.1128/jb.183.2.680-686.2001;
RA   Buss K.A., Cooper D.R., Ingram-Smith C., Ferry J.G., Sanders D.A.,
RA   Hasson M.S.;
RT   "Urkinase: structure of acetate kinase, a member of the ASKHA superfamily
RT   of phosphotransferases.";
RL   J. Bacteriol. 183:680-686(2001).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 1-399 IN COMPLEX WITH THE ATP
RP   ANALOGS ADP; AMP; ALF3 AND THE SUBSTRATE ACETATE, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, ACTIVE SITE, ACTIVITY REGULATION, COFACTOR,
RP   SUBUNIT, AND MUTAGENESIS OF ARG-91 AND ARG-241.
RX   PubMed=15647264; DOI=10.1074/jbc.m412118200;
RA   Gorrell A., Lawrence S.H., Ferry J.G.;
RT   "Structural and kinetic analyses of arginine residues in the active site of
RT   the acetate kinase from Methanosarcina thermophila.";
RL   J. Biol. Chem. 280:10731-10742(2005).
CC   -!- FUNCTION: Catalyzes the formation of acetyl phosphate from acetate and
CC       ATP. Can also catalyze the reverse reaction. Can also phosphorylate
CC       propionate, but has very low activity toward butyrate.
CC       {ECO:0000255|HAMAP-Rule:MF_00020, ECO:0000269|PubMed:15774882}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetate + ATP = acetyl phosphate + ADP; Xref=Rhea:RHEA:11352,
CC         ChEBI:CHEBI:22191, ChEBI:CHEBI:30089, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:456216; EC=2.7.2.1; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_00020, ECO:0000269|PubMed:11562377,
CC         ECO:0000269|PubMed:15647264, ECO:0000269|PubMed:15774882,
CC         ECO:0000269|PubMed:17999468, ECO:0000269|PubMed:2844814,
CC         ECO:0000269|PubMed:8226623};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_00020,
CC         ECO:0000269|PubMed:11562377, ECO:0000269|PubMed:15647264};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_00020,
CC         ECO:0000269|PubMed:11562377, ECO:0000269|PubMed:15647264};
CC       Note=Mg(2+). Can also accept Mn(2+). The Mg(2+) is bound between two
CC       conserved protein residues and the ATP phosphate groups.
CC       {ECO:0000255|HAMAP-Rule:MF_00020, ECO:0000269|PubMed:11562377,
CC       ECO:0000269|PubMed:15647264};
CC   -!- ACTIVITY REGULATION: Inhibited by diethylpyrocarbonate, hydroxylamine
CC       and phenylglyoxal. {ECO:0000269|PubMed:15647264,
CC       ECO:0000269|PubMed:8226623}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=71 uM for ATP {ECO:0000269|PubMed:15647264,
CC         ECO:0000269|PubMed:15774882, ECO:0000269|PubMed:17999468,
CC         ECO:0000269|PubMed:2844814, ECO:0000269|PubMed:8226623};
CC         KM=98 uM for ADP {ECO:0000269|PubMed:15647264,
CC         ECO:0000269|PubMed:15774882, ECO:0000269|PubMed:17999468,
CC         ECO:0000269|PubMed:2844814, ECO:0000269|PubMed:8226623};
CC         KM=1.5 mM for acetate {ECO:0000269|PubMed:15647264,
CC         ECO:0000269|PubMed:15774882, ECO:0000269|PubMed:17999468,
CC         ECO:0000269|PubMed:2844814, ECO:0000269|PubMed:8226623};
CC         KM=0.47 mM for acetyl phosphate {ECO:0000269|PubMed:15647264,
CC         ECO:0000269|PubMed:15774882, ECO:0000269|PubMed:17999468,
CC         ECO:0000269|PubMed:2844814, ECO:0000269|PubMed:8226623};
CC       Temperature dependence:
CC         Optimum temperature is 65 degrees Celsius. Protected from thermal
CC         inactivation by ATP. {ECO:0000269|PubMed:15647264,
CC         ECO:0000269|PubMed:15774882, ECO:0000269|PubMed:17999468,
CC         ECO:0000269|PubMed:2844814, ECO:0000269|PubMed:8226623};
CC   -!- PATHWAY: Metabolic intermediate biosynthesis; acetyl-CoA biosynthesis;
CC       acetyl-CoA from acetate: step 1/2. {ECO:0000255|HAMAP-Rule:MF_00020}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000255|HAMAP-Rule:MF_00020,
CC       ECO:0000269|PubMed:11133963, ECO:0000269|PubMed:11562377,
CC       ECO:0000269|PubMed:15647264, ECO:0000269|PubMed:17999468,
CC       ECO:0000269|PubMed:2844814}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_00020}.
CC   -!- SIMILARITY: Belongs to the acetokinase family. {ECO:0000255|HAMAP-
CC       Rule:MF_00020}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L23147; AAA72042.1; -; Unassigned_DNA.
DR   PIR; B49338; B49338.
DR   PDB; 1G99; X-ray; 2.50 A; A/B=1-408.
DR   PDB; 1TUU; X-ray; 2.50 A; A/B=1-399.
DR   PDB; 1TUY; X-ray; 3.00 A; A/B=1-399.
DR   PDBsum; 1G99; -.
DR   PDBsum; 1TUU; -.
DR   PDBsum; 1TUY; -.
DR   AlphaFoldDB; P38502; -.
DR   SMR; P38502; -.
DR   KEGG; ag:AAA72042; -.
DR   BRENDA; 2.7.2.1; 3281.
DR   SABIO-RK; P38502; -.
DR   UniPathway; UPA00340; UER00458.
DR   EvolutionaryTrace; P38502; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0008776; F:acetate kinase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0006085; P:acetyl-CoA biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006082; P:organic acid metabolic process; IEA:InterPro.
DR   GO; GO:0016310; P:phosphorylation; IEA:UniProtKB-UniRule.
DR   HAMAP; MF_00020; Acetate_kinase; 1.
DR   InterPro; IPR004372; Ac/propionate_kinase.
DR   InterPro; IPR000890; Aliphatic_acid_kin_short-chain.
DR   InterPro; IPR023865; Aliphatic_acid_kinase_CS.
DR   InterPro; IPR043129; ATPase_NBD.
DR   PANTHER; PTHR21060; PTHR21060; 1.
DR   Pfam; PF00871; Acetate_kinase; 1.
DR   PIRSF; PIRSF000722; Acetate_prop_kin; 1.
DR   PRINTS; PR00471; ACETATEKNASE.
DR   SUPFAM; SSF53067; SSF53067; 2.
DR   TIGRFAMs; TIGR00016; ackA; 1.
DR   PROSITE; PS01075; ACETATE_KINASE_1; 1.
DR   PROSITE; PS01076; ACETATE_KINASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Cytoplasm; Direct protein sequencing; Kinase;
KW   Magnesium; Metal-binding; Nucleotide-binding; Transferase.
FT   CHAIN           1..408
FT                   /note="Acetate kinase"
FT                   /id="PRO_0000107650"
FT   ACT_SITE        148
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00020,
FT                   ECO:0000269|PubMed:11133963, ECO:0000269|PubMed:15647264"
FT   BINDING         7
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000305"
FT   BINDING         14
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         91
FT                   /ligand="substrate"
FT   BINDING         208..212
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         283..285
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         331..335
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         384
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000305"
FT   SITE            180
FT                   /note="Transition state stabilizer"
FT   SITE            241
FT                   /note="Transition state stabilizer"
FT   MUTAGEN         7
FT                   /note="N->A: Almost abolishes catalytic activity. Requires
FT                   increased magnesium levels for activity. Strongly decreases
FT                   affinity for acetate."
FT                   /evidence="ECO:0000269|PubMed:11562377"
FT   MUTAGEN         7
FT                   /note="N->D: Almost abolishes catalytic activity. Strongly
FT                   decreases affinity for acetate."
FT                   /evidence="ECO:0000269|PubMed:11562377"
FT   MUTAGEN         10
FT                   /note="S->A,T: Strongly decreases catalytic activity.
FT                   Strongly decreases affinity for acetate."
FT                   /evidence="ECO:0000269|PubMed:11562377"
FT   MUTAGEN         11
FT                   /note="S->A: Decreases catalytic activity. Decreases
FT                   affinity for acetate."
FT   MUTAGEN         11
FT                   /note="S->T: Strongly decreases catalytic activity.
FT                   Strongly decreases affinity for acetate."
FT   MUTAGEN         12
FT                   /note="S->A: Decreases catalytic activity. Strongly
FT                   decreases affinity for acetate. Requires increased
FT                   magnesium levels for enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:11562377"
FT   MUTAGEN         12
FT                   /note="S->T: Decreases catalytic activity. Strongly
FT                   decreases affinity for acetate."
FT                   /evidence="ECO:0000269|PubMed:11562377"
FT   MUTAGEN         14
FT                   /note="K->A: Strongly decreases enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:11562377"
FT   MUTAGEN         14
FT                   /note="K->R: Reduces enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:11562377"
FT   MUTAGEN         91
FT                   /note="R->A,L: Decreases catalytic activity. Decreases
FT                   affinity for acetate."
FT                   /evidence="ECO:0000269|PubMed:15647264,
FT                   ECO:0000269|PubMed:17999468"
FT   MUTAGEN         93
FT                   /note="V->A: Decreases affinity for acetate."
FT                   /evidence="ECO:0000269|PubMed:15774882"
FT   MUTAGEN         122
FT                   /note="L->A: Decreases affinity for acetate."
FT                   /evidence="ECO:0000269|PubMed:15774882"
FT   MUTAGEN         148
FT                   /note="D->A,E,N: Abolishes catalytic activity. Decreases
FT                   affinity for acetate, but not for ATP."
FT                   /evidence="ECO:0000269|PubMed:11562377"
FT   MUTAGEN         179
FT                   /note="F->A: Decreases affinity for acetate."
FT                   /evidence="ECO:0000269|PubMed:15774882"
FT   MUTAGEN         211
FT                   /note="N->A: Slightly reduced enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:11562377"
FT   MUTAGEN         232
FT                   /note="P->A: Decreases affinity for acetate."
FT                   /evidence="ECO:0000269|PubMed:15774882"
FT   MUTAGEN         241
FT                   /note="R->K,L: Decreases catalytic activity. Strongly
FT                   reduced affinity for ATP."
FT                   /evidence="ECO:0000269|PubMed:15647264,
FT                   ECO:0000269|PubMed:17999468"
FT   MUTAGEN         384
FT                   /note="E->A: Almost abolishes catalytic activity. Strongly
FT                   decreases affinity for acetate. Requires strongly increased
FT                   magnesium levels for enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:11562377"
FT   STRAND          2..8
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   STRAND          13..19
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   TURN            20..23
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   STRAND          24..33
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   STRAND          36..38
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   STRAND          40..45
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   STRAND          50..54
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   HELIX           60..71
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   TURN            74..76
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   HELIX           82..84
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   STRAND          87..93
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   TURN            96..98
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   HELIX           107..115
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   HELIX           117..119
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   TURN            121..123
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   HELIX           124..137
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   STRAND          143..147
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   HELIX           150..154
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   HELIX           157..160
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   HELIX           166..172
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   HELIX           181..195
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   HELIX           199..201
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   STRAND          203..219
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   STRAND          222..227
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   STRAND          234..236
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   HELIX           249..257
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   HELIX           261..270
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   HELIX           273..278
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   HELIX           284..292
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   HELIX           296..319
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   STRAND          324..329
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   HELIX           330..335
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   HELIX           337..344
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   HELIX           348..350
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   HELIX           358..360
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   STRAND          374..379
FT                   /evidence="ECO:0007829|PDB:1G99"
FT   HELIX           384..397
FT                   /evidence="ECO:0007829|PDB:1G99"
SQ   SEQUENCE   408 AA;  44337 MW;  1A484DF8A7258800 CRC64;
     MKVLVINAGS SSLKYQLIDM TNESALAVGL CERIGIDNSI ITQKKFDGKK LEKLTDLPTH
     KDALEEVVKA LTDDEFGVIK DMGEINAVGH RVVHGGEKFT TSALYDEGVE KAIKDCFELA
     PLHNPPNMMG ISACAEIMPG TPMVIVFDTA FHQTMPPYAY MYALPYDLYE KHGVRKYGFH
     GTSHKYVAER AALMLGKPAE ETKIITCHLG NGSSITAVEG GKSVETSMGF TPLEGLAMGT
     RCGSIDPAIV PFLMEKEGLT TREIDTLMNK KSGVLGVSGL SNDFRDLDEA ASKGNRKAEL
     ALEIFAYKVK KFIGEYSAVL NGADAVVFTA GIGENSASIR KRILTGLDGI GIKIDDEKNK
     IRGQEIDIST PDAKVRVFVI PTNEELAIAR ETKEIVETEV KLRSSIPV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024